2,171
Views
2
CrossRef citations to date
0
Altmetric
Cardiology & Cardiovascular Disorders

Associations between serum electrolyte and short-term outcomes in patients with acute decompensated heart failure

, , , , , , , , , , , , , , , & ORCID Icon show all
Pages 155-167 | Received 03 Oct 2022, Accepted 03 Dec 2022, Published online: 15 Dec 2022

References

  • Chinese Heart Failure Association of Chinese Medical Doctor Association, National Expert Committee on Cardiovascular Diseases and Professional Committee on Heart Failure, Editorial Board of Chinese Journal of Heart Failure and Cardiomyopathy. Chinese expert consensus on the management of ion homeostasis in patients with heart failure. Chin J Heart Fail Cardiomyopathy. 2020;4(1):16–31.
  • Chinese Society of Cardiology of Chinese Medical Association, Editorial Board of Chinese Journal of Cardiology. Chinese guidelines for the diagnosis and treatment of heart failure. Chin J Cardiol. 2014;42(2):98–122.
  • Teerlink JR, Cotter G, Davison BA, et al. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAXAHF): a randomized, placebo-controlled trial. Lancet. 2013;381(9860):29–39.
  • Lee DS, Austin PC, Rouleau JL, et al. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA. 2003;290(19):2581–2587.
  • Gheorghiade M, Abraham WT, Albert NM, et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA. 2006;296(18):2217–2226.
  • Tavazzi L, Maggioni A, Lucci D, et al. Nationwide survey on acute heart failure in cardiology ward services in Italy. Eur Heart J. 2006;27(10):1207–1215.
  • Nieminen MS, Brutsaert D, Dickstein K, et al. Euro Heart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients—description of population. Eur Heart J. 2006;27(22):2725–2736.
  • Sato N, Gheorghiade M, Kajimoto K, et al. Hyponatremia and in-hospital mortality in patients admitted for heart failure (from the ATTEND Registry). Am J Cardiol. 2013;111(7):1019–1025.
  • Bergethon KE, Ju C, DeVore AD, et al. Trends in 30-day readmission rates for patients hospitalized with heart failure: findings from the get with the Guidelines-Heart Failure Registry. Circ Heart Fail. 2016;9(6):e002594.
  • Lukács KM, Lotti EK, Kristian A, et al. Short-term mortality risk of serum potassium levels in acute heart failure following myocardial infarction. Eur Heart J Cardiovasc Pharmacother. 2015;1(4):245–251.
  • Aldahl M, Jensen A-SC, Davidsen L, et al. Associations of serum potassium levels with mortality in chronic heart failure patients. Eur Heart J. 2017;38(38):2890–2896.
  • Gheorghiade M, Abraham WT, Albert NM, et al. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF Registry. Eur Heart J. 2007;28(8):980–988.
  • Corona G, Giuliani C, Parenti G, et al. Moderate hyponatremia is associated with increased risk of mortality: evidence from a meta-analysis. PLOS One. 2013;8(12):e80451.
  • Gheorghiade M, Rossi JS, Cotts W, et al. Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE trial. Arch Intern Med. 2007;167(18):1998–2005.
  • Grodin JL, Simon J, Hachamovitch R, et al. Prognostic role of serum chloride levels in acute decompensated heart failure. J Am Coll Cardiol. 2015;66(6):659–666.
  • Maaten JT, Damman K, Hanberg JS, et al. Hypochloremia, diuretic resistance, and outcome in patients with acute heart failure. Circ Heart Fail. 2016;9(8):e003109.
  • Ferreira JP, Girerd N, Duarte K, et al. Serum chloride and sodium interplay in patients with acute myocardial infarction and heart failure with reduced ejection fraction: an analysis from the high-risk myocardial infarction database initiative. Circ Heart Fail. 2017;10(2):e003500.
  • Jensen AS, Polcwiartek C, Søgaard P, et al. The association between serum calcium levels and short-term mortality in patients with chronic heart failure. Am J Med. 2019;132(2):200–208.e1.
  • Liu F, Zhang H, Li YM, et al. Hypocalcemia predicts 12‐month re‐hospitalization in heart failure. Eur J Clin Invest. 2020;50(8):e13261.
  • Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129–2200.
  • Wan HX, Lu XF. Diagnostics. In: Guan XR, editor. The detection of serum electrolyte. 9th ed. Beijing: People’s Medical Publishing House; 2018. p. 380–384.
  • White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30(4):377–399.
  • Ponikowski P, Jankowska EA. Pathogenesis and clinical presentation of acute heart failure. Rev Esp Cardiol. 2015;68(4):331–337.
  • Nohria A, Tsang SW, Fang JC, et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol. 2003;41(10):1797–1804.
  • Konstam MA, Gheorghiade M, Burnett JC, et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial. JAMA. 2007;297(12):1319–1331.
  • O'Connor CM, Starling RC, Hernandez AF, et al. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med. 2011;365(1):32–43.
  • Nolan J, Batin PD, Andrews R, et al. Prospective study of heart rate variability and mortality in chronic heart failure results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart). Circulation. 1998;98(15):1510–1516.
  • Macdonald JE, Struthers AD. What is the optimal serum potassium level in cardiovascular patients? J Am Coll Cardiol. 2004;43(2):155–161.
  • Krogager ML, Torp-Pedersen C, Mortensen RN, et al. Short-term mortality risk of serum potassium levels in hypertension: a retrospective analysis of Nationwide Registry Data. Eur Heart J. 2017;38(2):104–112.
  • Cooper LB, Benson L, Mentz RJ, et al. Association between potassium level and outcomes in heart failure with reduced ejection fraction: a cohort study from the Swedish Heart Failure Registry. Eur J Heart Fail. 2020;22(8):1390–1398.
  • Setoguchi S, Stevenson LW, Schneeweiss S. Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J. 2007;154(2):260–266.
  • Davis JD, Olsen MA, Bommarito K, et al. Timing and causes of readmission within 30-days of discharge from a heart failure hospitalization in a large multi-state healthcare cost and utilization project state inpatient database. J Am Coll Cardiol. 2015;65(10):A783.
  • Ross JS, Mulvey GK, Stauffer B, et al. Statistical models and patient predictors of readmission for heart failure: a systematic review. Arch Intern Med. 2008;168(13):1371–1386.
  • Madigan EA, Gordon NH, Fortinsky RH, et al. Rehospitalization in a national population of home health care patients with heart failure. Health Serv Res. 2012;47(6):2316–2338.
  • Howie-Esquivel J, Spicer JG. Association of partner status and disposition with rehospitalization in heart failure patients. Am J Crit Care. 2012;21(3):e65–e73.
  • Gheorghiade M, Gattis WA, O'Connor CM, et al. Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial. JAMA. 2004;291(16):1963–1971.
  • Klein L, O'Connor CM, Leimberger JD, et al. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study. Circulation. 2005;111(19):2454–2460.
  • Deubner N, Berliner D, Frey A, et al. Dysnatraemia in heart failure. Eur J Heart Fail. 2012;14(10):1147–1154.
  • Testani JM, Hanberg JS, Arroyo JP, et al. Hypochloremia is strongly and independently associated with mortality in patients with chronic heart failure. Eur J Heart Fail. 2016;18(6):660–668.
  • Cuthbert JJ, Pierpaolo P, Alan R, et al. Low serum chloride in patients with chronic heart failure: clinical associations and prognostic significance. Eur J Heart Fail. 2018;20(10):1426–1435.
  • Gwathmey JK, Copelas L, MacKinnon R, et al. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res. 1987;61(1):70–76.
  • Miura S, Yoshihisa A, Takiguchi T, et al. Association of hypocalcemia with mortality in hospitalized patients with heart failure and chronic kidney disease. J Card Fail. 2015;21(8):621–627.
  • Hamroun A, Pekar JD, Lionet A, et al. Ionized calcium: analytical challenges and clinical relevance. J Lab Precis Med. 2020;5:22–22.